Right now, it s a rehabilitation-based approach focused on improving symptoms and functioning so that kids can go back to their usual activities. says a clinician at a post-COVID rehab clinic.
For children with long COVID, there are no medications shown to directly target the condition. Instead, caregivers target their symptoms, which include nausea, dizziness, fatigue, head-aches, and a racing heart.
Stealth BioTherapeutics Announces Poster Presentation at American College of Cardiology (ACC) Annual Meeting
News provided by
Share this article
Share this article
BOSTON, May 17, 2021 /PRNewswire/ Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the company is presenting a poster at the 2021 American College of Cardiology (ACC) meeting being held virtually from May 15-17, 2021.
The poster entitled Elamipretide Improves Functional Assessments when Compared to the Natural History Progression of Cardiomyopathy-related Disease Symptomatology in Patients with Barth Syndrome: A TAZPOWER Analysis presents data from a Phase 3 retrospective natural history control trial comparing the cardiac and functional effects of elamipretide on Barth syndrome patients at week 72 of the open label extension por